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Relative Wall Thickness in Predicting
Ventricular Arrhythmia and Related Death*
Julius M. Gardin, MD, MBAV entricular arrhythmia (VA) and sudden car-diac death (SCD) remain important problemsin patients with heart failure (HF), despite
the reduction in VA-associated deaths attributable
to implantable cardioverter-deﬁbrillators (ICDs) (1).
The MADIT-CRT (Multicenter Automatic Deﬁbrillator
Implantation Trial With Cardiac Resynchronization
Therapy) study demonstrated that in patients with
mild HF, left ventricular ejection fraction (LVEF)
of #30%, and QRS duration $130 ms, the primary
endpoint of HF or all-cause mortality occurred in
17.2% of the CRT-ICD group versus 25.3% in the ICD-
only group (p ¼ 0.001), a difference driven primarily
by a 41% reduction in HF events in the CRT group
(2). Interestingly, there was no difference in beneﬁt
in patients with ischemic versus nonischemic cardio-
myopathy, even though myocardial scar and LVEF are
both associated with increased risk of VA and SCD (1).SEE PAGE 303In this issue of the Journal, Biton et al. (3) retro-
spectively evaluated 1,260 MADIT-CRT patients (70%
of the original cohort) who had mild ischemic (New
York Heart Association functional class I or II) or
nonischemic cardiomyopathy (New York Heart Asso-
ciation functional class II), left bundle branch block
(LBBB), and LVEF #30% (3). They aimed to determine
the value of echocardiographic LV relative wall
thickness (RWT: the ratio of twice LV diastolic pos-
terior wall thickness to left ventricular end-diastolic*Editorials published in the Journal of the American College of Cardiology
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of this paper to disclose.dimension [LVEDD]) versus other transthoracic
echocardiographic measurements in predicting risk
of VA or VA-associated death. Additionally, they
compared the association of CRT-D versus ICD-alone
therapy with respect to the change in RWT (i.e., LV
remodeling) at 1 year and the relationship of this
change to VA and VA death.
The researchers found that patients in the lowest
RWT tertile (<0.24) had an 83% increased risk for VA
and 68% increase in VA death (both p < 0.001)
compared with patients with higher RWT values. In
multivariable analyses, RWT was the best echocar-
diographic predictor for VA risk. Speciﬁcally, each
0.01-unit decrease in RWT was associated with 12%
and 10% increases in risk of VA and VA death,
respectively (both p < 0.001). Perhaps more impor-
tant, when the investigators compared echocardio-
graphic RWT in the CRT-D versus ICD-only groups
after 1 year of therapy, CRT-D was associated with a
greater increase in RWT. Remarkably, every 10% in-
crease in RWT in CRT-D patients was associated with
34% (p ¼ 0.027) and 36% (p ¼ 0.009) reductions,
respectively, in risk of VA and VA death.
In population studies, LV geometry assessed by
echocardiographic or cardiac magnetic resonance has
shown prognostic value for HF and death (4,5). An
RWT cut point has been used to differentiate those
with increased LV mass who have concentric hyper-
trophy (RWT of >0.42 in the current study [3] and
American Society of Echocardiography Guidelines [6]
and >0.45 in other studies [4,7]) versus eccentric LV
hypertrophy (LVH). In the current study, almost all
patients had an RWT of <0.32 (eccentric hypertro-
phy). Of interest, in the Framingham and Framing-
ham Offspring population studies, RWT added little
prognostic value to traditional cardiovascular disease
risk factors once LV mass was known (4) or LVH or LV
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Left ventricular (LV) measurements in patients with left bundle branch block and LV scar.
According to American Society of Echocardiography (ASE) guidelines, the recommended
approach to making the LV linear dimension measurements at end-diastole from 2-
dimensional echocardiograms is thatmeasurements should be obtained perpendicular to the
LV long-axis at, or immediately below, the mitral leaﬂet tips (A). LV wall thinning (possibly
reﬂecting myocardial scar) in the apical region (A) or mid septum (B, short-axis view) is not
reﬂected in the linear measurements (PWT and LVEDD) comprising the LV relative wall
thickness (A, B, C). M-mode echocardiogram (C) showing LV linearmeasurements performed
according to ASE recommendations; the LV apex is not imaged. LVEDD ¼ left ventricular
end-diastolic dimension; PWT¼ posterior wall thickness; VST¼ ventricular septal thickness.
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314enlargement was present (5). Conversely, in patients
with hypertension, Koren et al. (7) reported that those
with concentric LVH had the greatest mortality risk,
followed by eccentric hypertrophy and concentric
remodeling (normal LV mass and increased RWT).In contrast to Koren et al. (7), the current study
demonstrated that in patients with HF, increases in
RWT were associated with improved prognosis and
incremental predictive beneﬁt when added to other
echocardiographic predictors, such as LV mass, LVEF,
and left atrial, LV end-systolic, and LV end-diastolic
volumes (LVEDV). The difference in these ﬁndings
may relate partly to there being few patients with
concentric LVH in the current study. Alternatively, a
recent study in 127 patients with LVEF of#0.45 and an
ICD demonstrated that ventricular tachycardia/
ﬁbrillation (VF) was most frequent in patients with
eccentric LVH (43%), followed by those with concen-
tric remodeling/hypertrophy (30%), and lowest (12%)
with normal geometry (all p < 0.02) (8). A previous
MADIT-CRT study publication in patients with LBBB
reported that at 1 year, decreases in LV mass, corre-
lating directly with LVEDV change, were greater in
CRT-D versus ICD patients (9). In CRT-D patients,
ventricular tachycardia/VF/death occurred 3 times
less often in patients with versus without a 25% LV
mass decrease. The current study extended these ob-
servations by demonstrating incremental VA risk with
RWT decreases in the eccentric hypertrophy group,
the graded beneﬁt of RWT increases, and the beneﬁt of
CRT-D over ICD-alone therapy in increasing RWT.
The investigators suggest several plausible mech-
anisms to explain the association of decreased
RWT and VA risk: 1) ﬁbrosis and scar formation can
serve as a substrate for reentry circuits, early after-
depolarizations, and VA; 2) ﬁbrosis enhances the
ability of oxidative stress to induce spontaneous VF;
and 3) LV wall thickness, a measure of wall ﬁbrosis,
and LVEDD, a measure of remodeling, are indepen-
dently associated with VA risk.
The researchers performed additional analyses
that enhanced their ﬁndings. A model including
RWT demonstrated better ﬁt for predicting VA risk
compared with RWT’s 2 components, increased
LVEDD and lower LV wall thickness, both being
associated with higher risk. Also, RWT demonstrated
better ﬁt in a prognostic VA risk model than did the
LV mass/LVEDV ratio. Furthermore, RWT had signif-
icant predictive beneﬁt even after adjustment for
signiﬁcant baseline clinical differences.
The researchers appropriately acknowledged
important study limitations, including: 1) the retro-
spective, nonrandomized, post-hoc design poten-
tially introduced confounder bias; 2) exclusion of
patients without LBBB, potentially limiting general-
izability; and 3) not presenting a model including
clinical as well as echocardiographic predictors for VA
risk. Additionally, their use of linear dimensional
measurements (LV wall thickness and LVEDD)
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315introduced potential measurement errors (6,10),
including missing important areas of LV dilation and
wall thinning/scar (Figure 1). Furthermore, by study-
ing a cohort with RWT values at the lower end of the
population spectrum, a repeat (1-year) echocardio-
gram might have revealed higher RWT merely
because of random measurement ﬂuctuation, a
statistical artifact known as “regression to the mean”
(10). The current study did demonstrate a graded
(inverse) relationship between RWT and VA/VA
death at baseline and post-therapy, suggesting the
relationships reported are not artifactual.
It remains to be seen whether additional predictive
value may be gained using a 3-dimensional imaging
technique or imaging slice technology that can
identify and quantify extent of myocardial ﬁbrosis,
providing a more complete picture of myocardial
thickness/scar and volume. In this regard, Gulati et al.
(11) studied 472 patients with dilated cardiomyopathy
by cardiac magnetic resonance of the LV. After
adjustment for LVEF and conventional risk factors,both presence and extent of myocardial midwall
ﬁbrosis were independently and incrementally asso-
ciated with all-cause mortality, SCD, or aborted SCD;
the addition of ﬁbrosis to LVEF improved risk
reclassiﬁcation for these endpoints.
Biton et al. (3) are to be congratulated for providing
insights into patients with mild HF and LBBB
regarding the graded relationship of LV geometry to
VA risk, as well as the role of CRT in improving LV
geometry and decreasing VA risk. Additional follow-
up data in 2 to 3 years or longer would be of interest.
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